DCM
MDT icon

Delpha Capital Management’s Medtronic MDT Stock Holding History

Delpha Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-869
Closed -$70K – 769
2017
Q4 		$70K Buy
+869
New +$69.6K 0.08% 204

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Delpha Capital Management's MDT Position: Q1 2018 in Review

Delpha Capital Management sold out of Medtronic (MDT) in Q1 2018, closing a stake of 869 shares — an estimated $70K sold.

Delpha Capital Management first reported a position in MDT in Q4 2017 and held it in 1 quarter. The position peaked at $70K in Q4 2017. 1,382 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

  • Delpha Capital Management reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 869 Medtronic shares in Q1 2018, an estimated $70K.
  • Delpha Capital Management first reported a position in Medtronic in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Medtronic position peaked at $70K in Q4 2017.
  • 1,382 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.